Kylin Therapeutics, Purdue University, AeonClad, Millipore, Burnham Institute, Panagene, Copenhagen Inventor Group | GenomeWeb
Kylin Therapeutics Licenses pRNA IP from Purdue
 
Kylin Therapeutics said last week that it has obtained an exclusive license to RNA interference delivery technology from Purdue University.
 
The license agreement covers more than a dozen patent applications covering packaging RNA, or pRNA, which was invented by Peixuan Guo, former professor of molecular virology and biomedical engineering at Purdue.
 
Financial terms of the agreement were not disclosed.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.